NRXP NRX Pharmaceuticals, Inc. - Common Stock
$3.45
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026
52W Range
$2–$5
53% of range
Analyst Rating
BUY
11 analysts
Price Target
$38
+1009% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
NRXP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.45
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$2 – $5
NRXP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
NRXP
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
NRXP
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
NRXP
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
NRXP
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
NRXP
Peer Median
NRXP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
11 analysts
- Strong Buy 3 27.3%
- Buy 7 63.6%
- Hold 1 9.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
4 analysts · 2026-08-16
Median
$47.00
Mean
$38.25
← Below all targets
$3.45
Low
$10.00
High
$49.00
Median target
$47.00
+1262.3%
Mean target
$38.25
+1008.7%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.20%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.04 | $0.29 | -0.33% |
| Dec. 31, 2025 | $-0.01 | $-0.00 | -0.01% |
| Sept. 30, 2025 | $-0.50 | $-0.09 | -0.41% |
| June 30, 2025 | $-0.31 | $-0.21 | -0.10% |
| March 31, 2025 | $-0.21 | $-0.31 | 0.10% |
| Dec. 31, 2024 | $-0.77 | $-0.32 | -0.45% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NRXP | — | — | — | — | — | — |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| LENZ | $502M | -5.6 | — | -430.2% | -33.5% | — |
| AARD | $286M | -4.5 | — | — | -47.3% | — |
| NTHI | — | -2.6 | -51.8% | — | — | — |
| RANI | — | -3.0 | 58.9% | -1817.1% | -169.6% | — |
| CPIX | $60M | -20.9 | 17.6% | -6.4% | -11.9% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet 20
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $8M | |
| Receivables | $161.0K | |
| Prepaid Expense | $934.0K | |
| Current Assets | $9M | |
| PP&E (Net) | $63.0K | |
| PP&E (Gross) | $93.0K | |
| Accum. Depreciation | $30.0K | |
| Goodwill | $2M | |
| Intangibles | $925.0K | |
| Other Non-current Assets | $253.0K | |
| Total Assets | $13M | |
| Accounts Payable | $4M | |
| Current Liabilities | $29M | |
| Total Liabilities | $29M | |
| Common Stock | $32.0K | |
| Paid-in Capital | $291M | |
| Retained Earnings | $-307M | |
| Stockholders' Equity | $-16M | |
| Liabilities + Equity | $13M | |
| Shares Outstanding | 31,734,333 |
Income Statement 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $1M | $1M | $0 | |
| Cost of Revenue | $675.0K | $631.0K | $0 | |
| R&D Expense | $2M | $1M | $804.0K | |
| SG&A Expense | $5M | $4M | $3M | |
| Operating Expenses | $8M | $6M | $4M | |
| Operating Income | $-7M | $-5M | $-4M | |
| Interest Income | $6.0K | $5.0K | $4.0K | |
| Other Non-op | $-10M | $3M | $-2M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-17M | $-1M | $-6M | |
| EPS (Basic) | $-0.44 | $-0.04 | $-0.34 | |
| Shares (Basic) | 37,649,382 | 32,325,323 | 16,410,062 | |
| EBITDA | $-7M | $-5M | · |
Balance Sheet 20
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $27M | $7M | · | |
| Receivables | $206.0K | $181.0K | · | |
| Prepaid Expense | $2M | $467.0K | · | |
| Current Assets | $29M | $7M | · | |
| PP&E (Net) | $919.0K | $259.0K | · | |
| PP&E (Gross) | $990.0K | $306.0K | · | |
| Accum. Depreciation | $71.0K | $47.0K | · | |
| Goodwill | $2M | $2M | · | |
| Intangibles | $832.0K | $879.0K | · | |
| Other Non-current Assets | $224.0K | $276.0K | · | |
| Total Assets | $34M | $12M | · | |
| Accounts Payable | $3M | $4M | · | |
| Current Liabilities | $34M | $25M | · | |
| Total Liabilities | $34M | $26M | · | |
| Common Stock | $43.0K | $33.0K | · | |
| Paid-in Capital | $325M | $294M | · | |
| Retained Earnings | $-325M | $-308M | · | |
| Stockholders' Equity | $-170.0K | $-14M | · | |
| Liabilities + Equity | $34M | $12M | · | |
| Shares Outstanding | 43,157,744 | 33,471,315 | · |
Cash Flow 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| D&A | $71.0K | $63.0K | $1.0K | |
| Stock-based Comp | $139.0K | $151.0K | $12.0K | |
| Other Non-cash | · | $-3M | · | |
| Operating Cash Flow | $-9M | $-4M | $-3M | |
| Investing Cash Flow | $-684.0K | $-213.0K | $0 | |
| Stock Issued | · | $3M | $0 | |
| Net Stock Activity | · | $3M | · | |
| Financing Cash Flow | $30M | $3M | $8M | |
| Net Change in Cash | $20M | $-1M | $4M | |
| Taxes Paid | $0 | $0 | $0 |
Profitability 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Operating Margin | -590.8% | -444.0% | · | |
| Net Margin | -1500.5% | -133.9% | · | |
| EBITDA Margin | -590.8% | -438.1% | · | |
| ROA | -84.7% | -14.7% | · | |
| ROE | 92.3% | 7.3% | · |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Current Ratio | 0.9 | 0.3 | · | |
| Quick Ratio | 0.8 | 0.3 | · |
Efficiency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | |
| Receivables Turnover | 10.7 | 11.8 | · |
Valuation (TTM) 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Revenue TTM | $2M | · | · | |
| Net Income TTM | $-41M | $-30M | · | |
| Market Cap | $177M | $71M | · | |
| P/E | -1.6 | -0.8 | · | |
| P/S | 73.2 | · | · | |
| P/B | -1038.3 | -5.2 | · | |
| P / Cash Flow | · | -16.6 | · | |
| Earnings Yield | -63.3% | -121.6% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 53 filers · $47.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 21 (+9 vs prior Q) | 5 (+1 vs prior Q) | 17 (+5 vs prior Q) | 7 (+3 vs prior Q) | +6.6M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| B Group, Inc. | $16,735,327 | 4,091,767 | 35.63% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $6,618,270 | 1,618,159 | 14.09% | Shares |
| AMERIPRISE FINANCIAL INC | $3,798,498 | 928,728 | 8.09% | Shares |
| Balyasny Asset Management L.P. | $3,655,904 | 893,864 | 7.78% | Shares |
| CITADEL ADVISORS LLC | $2,781,376 | 680,043 | 5.92% | Shares |
| AdvisorShares Investments LLC | $2,695,384 | 659,018 | 5.74% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $1,858,570 | 454,418 | 3.96% | Shares |
| UBS Group AG | $1,154,092 | 282,174 | 2.46% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,046,733 | 255,889 | 2.23% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $927,612 | 226,800 | 1.98% | Call option |
| CITADEL ADVISORS LLC | $916,978 | 224,200 | 1.95% | Call option |
| VANGUARD FIDUCIARY TRUST CO | $747,317 | 182,718 | 1.59% | Shares |
| Bleakley Financial Group, LLC | $479,413 | 117,216 | 1.02% | Shares |
| STATE STREET CORP | $474,784 | 116,084 | 1.01% | Shares |
| JANE STREET GROUP, LLC | $436,293 | 106,673 | 0.93% | Shares |
| VANGUARD GROUP INC | $278,639 | 102,819 | 0.59% | Shares |
| NORTHERN TRUST CORP | $257,470 | 62,951 | 0.55% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $215,543 | 52,700 | 0.46% | Put option |
| Chicago Partners Investment Group LLC | $190,655 | 46,388 | 0.41% | Shares |
| Quadrature Capital Ltd | $178,344 | 43,605 | 0.38% | Shares |
| One Wealth Management Investment & Advisory Services, LLC | $177,134 | 43,309 | 0.38% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $157,874 | 38,600 | 0.34% | Shares |
| Global Retirement Partners, LLC | $136,197 | 33,300 | 0.29% | Shares |
| CITADEL ADVISORS LLC | $109,203 | 26,700 | 0.23% | Put option |
| TWO SIGMA INVESTMENTS, LP | $108,095 | 26,429 | 0.23% | Shares |
| TRUIST FINANCIAL CORP | $81,800 | 20,000 | 0.17% | Shares |
| ExodusPoint Capital Management, LP | $78,970 | 19,308 | 0.17% | Shares |
| JANE STREET GROUP, LLC | $76,074 | 18,600 | 0.16% | Call option |
| XTX Topco Ltd | $75,849 | 18,545 | 0.16% | Shares |
| Persistent Asset Partners Ltd | $66,773 | 16,326 | 0.14% | Shares |
| Cresset Asset Management, LLC | $61,350 | 15,000 | 0.13% | Shares |
| SJBENEN ADVISORY, LLC | $57,750 | 15,000 | 0.12% | Shares |
| Squarepoint Ops LLC | $53,849 | 13,166 | 0.11% | Shares |
| Ethos Financial Group, LLC | $51,357 | 15,900 | 0.11% | Shares |
| MILLENNIUM MANAGEMENT LLC | $50,327 | 12,305 | 0.11% | Shares |
| BlackRock, Inc. | $29,092 | 7,113 | 0.06% | Shares |
| CITIGROUP INC | $24,507 | 5,992 | 0.05% | Shares |
| Vanguard Global Advisers, LLC | $23,612 | 5,773 | 0.05% | Shares |
| MORGAN STANLEY | $21,170 | 5,176 | 0.05% | Shares |
| SBI Securities Co., Ltd. | $20,863 | 5,101 | 0.04% | Shares |
| MARSHALL WACE, LLP | $17,918 | 4,381 | 0.04% | Shares |
| Tower Research Capital LLC (TRC) | $13,681 | 3,345 | 0.03% | Shares |
| WELLS FARGO & COMPANY/MN | $8,180 | 2,000 | 0.02% | Shares |
| ROYAL BANK OF CANADA | $8,000 | 2,000 | 0.02% | Shares |
| BARCLAYS PLC | $3,681 | 900 | 0.01% | Shares |
| OSAIC HOLDINGS, INC. | $2,454 | 600 | 0.01% | Shares |
| HRT FINANCIAL LP | $411 | 100,724 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $274 | 67 | 0.00% | Shares |
| JPMORGAN CHASE & CO | $136 | 34 | 0.00% | Shares |
| Larson Financial Group LLC | $90 | 22 | 0.00% | Shares |
| Virtu Financial LLC | $68 | 16,614 | 0.00% | Shares |
| Steward Partners Investment Advisory, LLC | $4 | 1 | 0.00% | Shares |
| Avion Wealth | $1 | 294 | 0.00% | Shares |
Company insiders 13 insiders · 3 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Robert Besthof | Interim CEO | March 8, 2022 A | 23,710 | 0 | 0 | $0 |
| Jonathan C Javitt | Chief Scientist | Aug. 23, 2023 P | 446,332 | 0 | 0 | $0 |
| Alessandra Daigneault | General Counsel & Secretary | Sept. 2, 2021 A | 31,584 | 0 | 0 | $0 |
| Chaim Hurvitz | Director | Nov. 18, 2022 P | 500,000 | 0 | 0 | $0 |
| Patrick John Flynn | Director | Oct. 21, 2022 A | 35,209 | 0 | 0 | $0 |
| Sharon Glied | Director | Oct. 21, 2022 A | 13,168 | 0 | 0 | $0 |
| Aaron Gorovitz | Director | Oct. 21, 2022 A | 16,678 | 0 | 0 | $0 |
| Herbert Raymond Mcmaster | Director | Aug. 26, 2021 A | 18,300 | 0 | 0 | $0 |
| Daniel Troy | Director | May 24, 2021 A | 43,093 | 0 | 0 | $0 |
| Daniel C. Javitt | 10% owner | Nov. 30, 2022 S | 9,634,793 | 0 | 0 | $0 |
| Polar Securities Inc. | 10% owner | March 13, 2020 S | 488,036 | 0 | 0 | $0 |
| BRAC Lending Group LLC | — | May 24, 2021 D | 590,435 | 0 | 0 | $0 |
| William Fricker | — | May 24, 2021 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Daniel C. Javitt | Sept. 13, 2022 | — | Initial filing | Passive investment | SEC |
| Jonathan C. Javitt ×4 filings | June 17, 2022 | — | Initial filing | — | SEC |
| David M. Nussbaum, Steven Levine, BRAC Lending Group LLC ×2 filings | June 4, 2021 | — | Initial filing | Passive investment | SEC |
| Big Rock Partners Sponsor, LLC, Richard Ackerman ×3 filings | May 26, 2021 | — | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.